Exenatide is an insulinotropic peptide drug for type 2 diabetes treatment with low risk of hypoglycemia, and is administrated by subcutaneous injection. Oral administration is the most preferred route for life...
from Most Recent Articles: Journal of Nanobiotechnology https://ift.tt/2Ye6aSU
via IFTTT
No comments:
Post a Comment